Characterization of Thermoluminescent Dosimetry Systems According to the IEC 62387:2020 Standard.

ABSTRACT: A need for detailed testing of individual monitoring systems used in accredited service at the Vinca Institute of Nuclear Sciences was recognized following changes in individual, workplace, and environmental monitoring passive dosimetry systems acceptability criteria stated in IEC 62387:2020 and changes related to reference fields used in radiation protection defined in ISO 4037:2019. Reliability and accuracy of dosimetry data acquired by passive dosimetry systems used for individual monitoring is assured by carrying out type tests. In this manner, the effects of different radiation influence quantities are examined. Passive dosimetry systems comprised of an LiF:Mg,Ti (TLD-100) detector card placed in two different holder models (8814 and 8850) and the Harshaw TLD Model 6600 Plus Automated Reader were tested. Type tests were done in an extended range of photon energies from 40 keV up to 1.25 MeV, angle of incidence values of ±45° and ± 60° for both vertical and horizontal dosimeter orientation, and in the dose range from 0.05 mSv to 1 Sv. Both dosimetry system configurations perform in line with IEC 62387:2020 within mandatory range for tested influence quantities. Dosimeters that use the 8850 holder type showed less pronounced energy and angular dependence of the response in the low-energy range.

UNCERTAINTY ASSOCIATED WITH THE USE OF SOFTWARE SOLUTIONS UTILIZING DICOM RDSR FOR SKIN DOSE ASSESSMENT IN INTERVENTIONAL RADIOLOGY AND CARDIOLOGY.

PURPOSE: The purpose of this work is to provide a comprehensive analysis of uncertainties associated with the use of software solutions utilizing DICOM RDSRs for skin dose assessment in the interventional fluoroscopic environment. METHODS AND RESULTS: Three different scenarios have been defined for determining the overall uncertainty, each with a specific assumption on the maximum deviations of factors affecting the calculated dose. Relative expanded uncertainty has been calculated using two approaches: the law of propagation of uncertainty and the propagation of distributions based on the Monte Carlo method. According to the propagation of uncertainty, it is estimated that the lowest possible relative expanded uncertainty of ~13% (at the 95% level of confidence, i.e. with the coverage factor of k = 2 assuming normal distribution) could only be achieved if all sources of uncertainties are carefully controlled, whereas maximum relative expanded uncertainty could reach up to 61% if none of the influencing parameters are controlled properly. When the influencing parameters are reasonably well-controlled, realistic relative expanded uncertainty amounts to 28%. Values for the relative expanded uncertainty obtained from the Monte Carlo propagation of distributions concur with the results obtained from the propagation of uncertainty to within 3% in all three considered scenarios, validating the assumption of normality. CONCLUSIONS: The overall skin dose relative uncertainty has been found to range from 13 to 61%, emphasizing the importance of adequate analysis and control of all relevant uncertainty sources.

Vendor-independent skin dose mapping application for interventional radiology and cardiology.

PURPOSE: The purpose of this paper is to present and validate an originally developed application SkinCare used for skin dose mapping in interventional procedures, which are associated with relatively high radiation doses to the patient's skin and possible skin reactions. METHODS: SkinCare is an application tool for generating skin dose maps following interventional radiology and cardiology procedures using the realistic 3D patient models. Skin dose is calculated using data from Digital Imaging and Communications in Medicine (DICOM) Radiation Dose Structured Reports (RDSRs). SkinCare validation was performed by using the data from the Siemens Artis Zee Biplane fluoroscopy system and conducting "Acceptance and quality control protocols for skin dose calculating software solutions in interventional cardiology" developed and tested in the frame of the VERIDIC project. XR-RV3 Gafchromic films were used as dosimeters to compare peak skin doses (PSDs) and dose maps obtained through measurements and calculations. DICOM RDSRs from four fluoroscopy systems of different vendors (Canon, GE, Philips, and Siemens) were used for the development of the SkinCare and for the comparison of skin dose maps generated using SkinCare to skin dose maps generated by different commercial software tools (Dose Tracking System (DTS) from Canon, RadimetricsTM from Bayer and RDM from MEDSQUARE). The same RDSRs generated during a cardiology clinical procedure (percutaneous coronary intervention-PCI) were used for comparison. RESULTS: Validation performed using VERIDIC's protocols for skin dose calculation software showed that PSD calculated by SkinCare is within 17% and 16% accuracy compared to measurements using XR-RV3 Gafchromic films for fundamental irradiation setups and simplified clinical procedures, respectively. Good visual agreement between dose maps generated by SkinCare and DTS, RadimetricsTM and RDM was obtained. CONCLUSIONS: SkinCare is proved to be very convenient solution that can be used for monitoring delivered dose following interventional procedures.